Literature DB >> 6802760

Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.

S E Gardner, D C Anderson, B J Webb, A E Stitzel, M S Edwards, R E Spitzer, C J Baker.   

Abstract

The relative roles of serum factors required for opsonization of type XIV Streptococcus pneumoniae were investigated by means of luminol-enhanced chemiluminescence (CL), bactericidal, and immunofluorescence assays employing adult sera containing high (>1,000 ng of antibody nitrogen per ml) or low (<200 ng of antibody nitrogen per ml) antibody concentrations as determined by radioimmunoassay. Specific antibody concentration correlated directly with both total and heat-labile CL activity (P < 0.005) and with the bactericidal index (P < 0.05) at a serum concentration of 10%. The importance of specific antibody as an opsonin was confirmed by the abolition of CL activity and immunoglobulin immunofluorescence observed after absorption of heated sera with type XIV pneumococcal cells and by the dose response in CL and bactericidal activity observed with the addition of immunoglobulin G to hypogammaglobulinemic serum. A role for the classical complement pathway in opsonization was indicated by significantly greater CL integrals for high-antibody sera than for low-antibody sera depleted of factor D and by the bactericidal activity noted for untreated, but not magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N-tetraacetic acid-chelated low-antibody sera. The alternative pathway contributed more than half of the CL activity of both high- and low-antibody sera. However, after magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N-tetraacetic acid chelation, only sera with high antibody concentrations or agammaglobulinemic serum reconstituted with immunoglobulin G with high specific antibody levels supported significant bactericidal activity. Therefore, type-specific antibody and complement promote opsonization of type XIV S. pneumoniae, and this may occur via either complement pathway. These results suggest that CL is a suitable tool to delineate serum factors and their contribution to opsonization, but results must be related to other functional assays.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802760      PMCID: PMC351119          DOI: 10.1128/iai.35.3.800-808.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

2.  Influence of antibodies and thermolabile serum factors on the bactericidal activity of human neutrophil granulocytes.

Authors:  C O Solberg; K E Christie; B Larsen; O Tonder
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-04

Review 3.  From the center for disease control. Epidemiology of pneumococcal serotypes in the United States, 1978--1979.

Authors:  C V Broome; R R Facklam; J R Allen; D W Fraser; R Austrian
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

4.  The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.

Authors:  J A Winkelstein; J A Bocchini; G Schiffman
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

5.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

6.  Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.

Authors:  G S Giebink; J E Foker; Y Kim; G Schiffman
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

7.  Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation.

Authors:  R B Polhill; S L Newman; K M Pruitt; R B Johnston
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

8.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

9.  Serotypes of Streptococcus pneumoniae causing disease.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

10.  Participation of immunoglobulin and the alternative complement pathway in opsonization of Bacteroides fragilis and Bacteroides thetaiotaomicron.

Authors:  A B Bjornson; H S Bjornson
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

View more
  4 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.

Authors:  W T Jansen; J Gootjes; M Zelle; D V Madore; J Verhoef; H Snippe; A F Verheul
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

3.  Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6.

Authors:  C Mold; K M Edwards; H Gewurz
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

4.  Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.

Authors:  J H Braconier; H Odeberg; A G Sjöholm
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.